In the News
American Academy of HIV Medicine Statement on the Cuts to the Department of Health and Human Services
On Tuesday, April 1, the Trump Administration began sweeping cuts to the U.S. Department of Health and Human Services (HHS),
In the News
Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering Six Months of Protection
Gilead Sciences, Inc. (Nasdaq: GILD) announced [on June 18, 2025] that the U.S. Food and Drug Administration (FDA) has approved
In the News
Two HIV Vaccine Trials Show Proof of Concept for Pathway to Broadly Neutralizing Antibodies
A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce
In the News
American Academy of HIV Medicine Statement on Recent White House Executive Orders
On Monday, January 20, 2025, the Trump White House issued numerous executive orders, and several affect those in the LGBTQIA
In the News
The American Academy of HIV Medicine Announces Second Year for Fellowship to Improve HIV Prevention and PrEP Access
On February 3, the American Academy of HIV Medicine (AAHIVM) announced the second year of the Dr. Dawn K. Smith
In the News
As Prevention Strategy for Sexually Transmitted Infections Rolls Out, Experts Highlight both Promise and Knowledge Gaps
As health care services begin offering doxycycline to prevent bacterial sexually transmitted infections (STIs), real-world evidence demonstrates that the postexposure
In the News
First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet
Gilead Sciences, Inc. (Nasdaq: GILD) today [March 11] presented the first data from its ongoing Phase 1 study investigating two
FDA Approves Drug to Treat HIV Infection in Newborns
The U.S. Food and Drug Administration (FDA) has approved Tivicay PD tablets for oral suspension (dolutegravir) to treat HIV infection
Virtual intervention reduces substance use in American Indians and Alaska Natives
Emerging adults who participated in workshops combining evidence-based interventions and traditional practices reported reduced cannabis, alcohol use, and anxiety. A
New Regulation Prohibits Federal Medicaid Funds From Covering Gender-Affirming Medical Care for Young People
On August 11, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a much-anticipated final rule prohibiting federal Medicaid or Children’s
Study Shows LGBTQ+ Youth in the U.S. Face High Rates of Suicidality and Victimization, Worsened by Anti-LGBTQ+ Politics
May 6, 2026 — The Trevor Project, the leading suicide prevention and crisis intervention organization for LGBTQ+ young people, released The 2025
In the News
Fellowship to Expand HIV Prevention and PrEP Access Now In Its Third Year
The American Academy of HIV Medicine (AAHIVM) announces the third year of the Dr. Dawn K. Smith HIV Prevention Clinical Fellowship, which is funded by a grant through ViiV Healthcare.
In the News
NIH-Supported Trial Reduces HIV Incidence By 70 Percent In Rural Populations
A study funded by the National Institutes of Health (NIH) reduced new HIV cases by 70 percent in rural Kenya and Uganda by pairing digital tools with tailored HIV services delivered by community health workers and clinicians.
In the News
ViiV Healthcare Reports Long-Acing Injectable Cabenuva Effectively Maintains Viral Suppression in Adolescents Living with HIV, with >97 Percent Preferring Injections Over Daily Oral Treatment
ViiV Healthcare announced week 96 and end-of-study results from the phase I/II IMPAACT 2017 (MOCHA) study, the first trial to evaluate a complete injectable long-acting treatment regimen in adolescents living with HIV.
In the News
New Data Show Over 91 Percent Viral Suppression Rate Among Ryan White HIV/AIDS Program Patients
The Health Resources and Services Administration (HRSA) released new data, marking a record-breaking 91.4 percent of patients receiving HIV medical care through the Ryan White HIV/AIDS Program were virally suppressed, significantly exceeding the national viral suppression rate.
In the News
U.S. HIV Response is Under Significant Strain
On April 14, the American Academy of HIV Medicine (AAHIMV), along with other members of the Emergency HIV Clinical Response Task Force (the Task Force), released updated data quantifying the scope and nature of HIV service disruptions resulting from harmful policy and funding decisions. The findings from the survey lay bare the dangerous barriers to care facing patients and underscore significant strain in the HIV response in the United States.
In the News
One dose of antibiotic treats early syphilis as well as three doses
Researchers funded by the National Institutes of Health (NIH) have found that a single injection of the antibiotic benzathine penicillin
In the News
AAHIVM Credentialing Program Changes
The Academy is committed to developing a workforce of HIV providers ready to care for the next generation of those with and at risk of HIV. To further uphold this mission and better support our credentialing applicants, we’re making some changes to our credentialing program.
In the News
State Medicaid Officials Project Flat Enrollment Post Unwinding but Increased Spending and Budget Pressures, as States Prepare for Impact of Federal Medicaid Policy Changes
As states completed the “unwinding” of pandemic-era continuous coverage, Medicaid enrollment fell 7.6 percent in FY 2025 and is expected to
In the News
Treating opioid addiction in jails improves treatment engagement, reduces overdose deaths and reincarceration
A study supported by the National Institutes of Health (NIH) finds that individuals who received medication for opioid use disorder